PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, featuring promising developments across a variety of professional medical and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA delivers a safer, extra trustworthy alternate for therapeutic use